Clinical trials
Pulmonary clinical trials
Below are recruiting pulmonary clinical trials, each written for real people, not researchers. We’re tracking 1,310 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07585214Recruiting
Screening for lung and heart disease using chest X-rays
This study uses chest X-rays to screen for early signs of lung and heart disease in people without known serious disease. Researchers want to understand how well routine chest imaging can catch health problems early.
Dazhou, SichuanAges 18 years+ - NCT07583849RecruitingPhase 3
Testing a new inhaled powder for COPD symptoms
This study tests whether a new inhaled medication called HSK39004 can help people with COPD breathe better and reduce shortness of breath. You'll receive either the medication or a placebo (inactive powder) and be monitored for safety and effectiveness.
Beijing, Beijing MunicipalityAges 40–80 - NCT07579052Recruiting
Predicting When Severely Ill COPD Patients Can Stop Breathing Machines
This study tests a prediction tool called CLEAR to help doctors know when patients with severe COPD lung disease are ready to stop using breathing machines (ventilators) in the ICU. The tool may help doctors make faster, safer decisions about when patients can breathe on their own.
Asyut, Assuit EgyptAges 40 years+ - NCT07570394Recruiting
Breztri safety study for COPD and asthma patients in Korea
This study collects information on how Breztri (a medicine for COPD and asthma) works in real-life patients who have just started taking it. It helps ensure the medicine is safe and effective for people like you.
ChuncheonAges Any age - NCT07572383RecruitingPhase 2
Imaging Study of Immunosuppression for Progressive Lung Fibrosis
This study uses advanced imaging to see how immunosuppressive medications (like mycophenolate or prednisone) affect lung scarring in patients with certain types of lung fibrosis. You would have imaging scans and breathing tests to track changes over time.
Boston, MassachusettsAges 18–80 - NCT06727669Recruiting
Long-term study of blood clotting and bleeding disorders
This study observes patients with blood clotting or bleeding disorders over time to collect health information and improve care.
Beijing, Beijing MunicipalityAges Any age - NCT06354790Recruiting
LAMA2-related dystrophy natural history study in children
This study follows children with LAMA2-related muscular dystrophy to learn how the condition changes over time. It does not test a new treatment, but helps researchers understand the disease better.
GarchesAges 2–15 - NCT07566195RecruitingPhase 3
Long-term Safety of Tozorakimab in COPD Patients
This study follows patients who previously took part in a tozorakimab trial to see how safe the drug is over time. Tozorakimab is an antibody treatment designed to reduce flare-ups (exacerbations) in people with COPD, a chronic lung disease.
Aix-en-ProvenceAges 18–99 - NCT06733168Recruiting
Electric imaging to guide breathing machine settings for ARDS
This trial tests whether using a special imaging technique (electrical impedance tomography) to set the breathing machine's pressure can improve oxygen levels and lung function in patients with moderate to severe ARDS, a serious lung condition.
HanoiAges 18 years+ - NCT07556185Recruiting
Testing a home heart health monitoring app for kids
This study tests whether young people with heart conditions can use a home monitoring app called Medly to track their symptoms and weight. The app may help doctors catch problems earlier and keep kids healthier at home.
Toronto, OntarioAges 8–18 - NCT06732674Recruiting
Home-based care for lung disease in rheumatic conditions
This trial tests whether people with lung disease caused by a rheumatic condition can safely manage their care at home using a smartphone or tablet. It aims to see if home monitoring is as effective as in-person visits for keeping your lungs healthy.
OsloAges 18 years+ - NCT07536035Recruiting
Comparing Hospital Care Pathways for Acute Medical Illness
This study compares two different hospital care pathways for adults admitted with acute medical emergencies like infections, falls, or COPD flare-ups. The goal is to see which pathway provides more appropriate and effective care.
SingaporeAges 21 years+ - NCT06749886RecruitingPhase 2
Tislelizumab plus chemo for advanced lung cancer after prior immunotherapy
This trial tests a drug called Tislelizumab (an immunotherapy) combined with chemotherapy for people with advanced NSCLC who have already been helped by a different immunotherapy. It's a second-line option for those who did well on their first immunotherapy but now need another treatment.
ShanghaiAges 18 years+ - NCT06749860RecruitingPhase 2
Targeted drug combo for HER2-positive advanced lung cancer
This trial tests a combination of three drugs (Disitamab Vedotin, Tislelizumab, and Bevacizumab) for people with advanced non-small cell lung cancer that has a specific change in the HER2 gene or protein. The goal is to see if this combination can shrink tumors or slow the cancer's growth.
ShanghaiAges 18 years+ - NCT07527299Recruiting
Varipulse catheter study for persistent atrial fibrillation
This study tests a new catheter to treat persistent atrial fibrillation (a type of irregular heartbeat lasting more than 7 days but less than a year). It aims to isolate the pulmonary veins and superior vena cava to restore normal rhythm. Some participants may also receive a left atrial appendage occlusion device if needed.
Birmingham, AlabamaAges 18–80 - NCT07525518Enrolling by invitation
Okami Medical Device Patient Registry
This is a registry—a database that tracks patient outcomes—for people receiving Okami Medical devices. By joining, you help doctors understand how well these devices work and whether they're safe over time.
Aurora, ColoradoAges 18 years+ - NCT07529847Recruiting
Breathing Techniques to Help Asthma Control
This study compares two special breathing techniques—alternating which nostril you breathe through and a method called Buteyko breathing—to see which helps asthma patients breathe easier and improve lung function. You'll practice these techniques and we'll measure how well they work for you.
IslamabadAges 18–45 - NCT07529821Recruiting
Breathing and Walking Exercise for Early High Blood Pressure
This study tests whether combining special breathing techniques with treadmill walking can help lower blood pressure and improve breathing function in people with slightly elevated blood pressure. If you have early-stage high blood pressure, this trial might help you avoid needing medication.
IslamabadAges 20–55 - NCT07529834Recruiting
Breathing and Cycling for High Blood Pressure
This study tests whether combining special breathing techniques (Pilates and diaphragmatic breathing) with moderate cycling exercise can help lower blood pressure and improve lung function in people with high blood pressure. You'll practice these techniques over several weeks to see if they reduce your blood pressure more effectively than exercise alone.
IslamabadAges 20–55 - NCT07531771Recruiting
Breathing Exercises for Early-Stage COPD
This study tests whether two types of breathing exercises—pursed lip breathing (slowing your breath) and alternate nostril breathing—can improve lung function and quality of life in people with mild COPD. You'll learn and practice these techniques to see if they help you breathe better.
IslamabadAges 40–65 - NCT07528066Recruiting
Surgery After Chemotherapy and Immunotherapy for Advanced Lung Cancer
This study follows patients with advanced non-small cell lung cancer (NSCLC) who receive combination chemotherapy and immunotherapy before surgery. Researchers will track how well surgery works after this pre-surgical treatment and compare different surgical approaches.
Fuzhou, FujianAges Any age - NCT06753981Recruiting
Triple drug therapy for new PAH patients
This trial tests whether a combination of three medications works well and is safe for people newly diagnosed with pulmonary arterial hypertension (PAH) that is not low-risk. It aims to see if starting with triple therapy early can improve outcomes.
Jinan, ShandongAges 18–80 - NCT07516184Recruiting
Testing a breathing device to diagnose asthma
This study tests a portable handheld device that measures airway function to help diagnose asthma. Researchers want to see if this device can accurately identify asthma in people with breathing symptoms like wheezing and shortness of breath.
BeijingAges 18–75 - NCT07518446Recruiting
Health Screening for Adults Starting Psychiatric Care
This study checks the physical health of adults beginning treatment for serious mental illnesses like schizophrenia or depression at two Danish clinics. It aims to catch health problems early that people with these conditions often experience.
CopenhagenAges 18 years+
Hear when a new Pulmonary trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for pulmonary?
- Yes. Clin2 currently lists 1,310 recruiting pulmonary studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a pulmonary trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a pulmonary trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.